Damloran Pharmaceutical (XTEH:DAML1) Construction In Progress: IRR0.00 Mil (As of . 20)


XTEH:DAML1 Damloran Pharmaceutical XTEH:DAML1
27 GF Score
Price IRR10,100.00
View Full Analysis

What is Damloran Pharmaceutical Construction In Progress?

Damloran Pharmaceutical XTEH:DAML1 27 Construction In Progress is IRR0.00 Mil as of . 20. GuruFocus rates XTEH:DAML1 with a GF Score™ of 27/100.

Damloran Pharmaceutical Construction In Progress Historical Data

* Premium members only.

The historical data trend for Damloran Pharmaceutical's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Damloran Pharmaceutical Construction In Progress Chart

Damloran Pharmaceutical Annual Data
Trend
Construction In Progress

Damloran Pharmaceutical Semi-Annual Data
Construction In Progress
XTEH:DAML1
27GF Score
Damloran Pharmaceutical XTEH:DAML1
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Damloran Pharmaceutical Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of IRR0.00 Mil mean?
Damloran Pharmaceutical (XTEH:DAML1) has a Construction In Progress of IRR0.00 Mil as of . 20. Construction in Progress records the amount of construction work that is not complete. View historical data on Damloran Pharmaceutical and its competitors.
Is Damloran Pharmaceutical's Construction In Progress too high?
Damloran Pharmaceutical's current Construction In Progress is IRR0.00 Mil. Overall, Damloran Pharmaceutical has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Damloran Pharmaceutical's Construction In Progress compare to IMNPQ?
Damloran Pharmaceutical's Construction In Progress of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Damloran Pharmaceutical and its competitors. Damloran Pharmaceutical's current Construction In Progress is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Damloran Pharmaceutical stock overvalued right now?
Damloran Pharmaceutical (XTEH:DAML1) has a current Construction In Progress of IRR0.00 Mil. The current Construction In Progress is IRR0.00 Mil. Damloran Pharmaceutical's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Damloran Pharmaceutical (XTEH:DAML1), the current Construction In Progress is IRR0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Damloran Pharmaceutical Business Description

Address No.4, Parvin Alley, West Fatemi Avenue, Tehran, IRN
Damloran Pharmaceutical manufactures and markets livestock and poultry pharmaceuticals. The Company offers animal health products to protect and improve health and hygiene of society to treat and to enhance the quality of animals' life.
27GF Score

Get the complete analysis for XTEH:DAML1

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

IRR10,100.00
Price